Acetaminophen Hepatotoxicity SIRT1 and miR-19b Expression Data

Experimental data from Xing Liu's 2020 study investigates the role of SIRT1 and miR-19b in acetaminophen-induced liver injury. The dataset includes molecular measurements from human LO2 cells and mouse liver tissue exposed to APAP. It captures expression levels of SIRT1, Nrf2, and related antioxidant genes under various experimental conditions.

Use Cases

• Analyze the correlation between APAP exposure levels and SIRT1 mRNA/protein upregulation in LO2 cells and mouse liver.
• Model the effect of SIRT1 knockdown via lentivirus on Nrf2 expression and downstream antioxidant gene levels.
• Investigate the regulatory relationship between miR-19b overexpression and the induction of SIRT1 expression in vitro and in vivo.
• Assess the impact of the SIRT1 activator SRT1720 (30 mg/kg) on Nrf2-mediated antioxidant defense reversal of liver injury.

Strengths

• Data originates from a peer-reviewed scientific study with a clear mechanistic hypothesis on drug-induced hepatotoxicity.
• Includes results from both in vitro (human LO2 cells) and in vivo (mouse) experimental models for cross-validation.
• Investigates a specific molecular pathway involving SIRT1, Nrf2, and miR-19b with defined experimental interventions like knockdown and activation.

Limitations

• The dataset scope is confined to the specific molecular targets (SIRT1, Nrf2, miR-19b) studied, limiting broader genomic or proteomic analysis.
• Sample sizes for experimental groups (e.g., number of mice per condition) are not specified, making statistical power assessment impossible.
• Data is from a single 2020 study, and findings may not be replicated or generalizable to other hepatotoxic agents or models.

Provenance

Source

Dryad digital repository, authored by Xing Liu.

Collection Method

Experimental data from laboratory studies on human LO2 cell lines and mouse models involving APAP exposure, SIRT1 knockdown/activation, and miR-19b modulation.

Freshness

Last updated 2020-06-24.